- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: ivermectin AND covid-19.
Displaying page 1 of 1.
EudraCT Number: 2021-002445-15 | Sponsor Protocol Number: Prevent-COVID | Start Date*: 2021-09-27 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: Placebo-kontrollierte randomisierte doppel-blinde Phase III Studie zur Wirksamkeit und Sicherheit von Ivermectin Tabletten (Driponin®) für die Prophylaxe der COVID-19 Erkrankung bei im Haushalt leb... | ||
Medical condition: COVID-19 Post-Expositionsprophylaxe | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001938-19 | Sponsor Protocol Number: mdc-TTG-CT-002 | Start Date*: 2022-03-10 | |||||||||||
Sponsor Name:MedinCell S.A. | |||||||||||||
Full Title: A multicentre randomised, Double-Blind, Placebo-controlled, Study to evaluate the efficAcy and safety of oral IVErmectin tablets in the prevention of COVID-19 (the SAIVE Trial) | |||||||||||||
Medical condition: Prophylaxis of COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001994-66 | Sponsor Protocol Number: ECIT-PRO19 | Start Date*: 2020-05-06 |
Sponsor Name:Fundació Assistencial Mútua Terrassa | ||
Full Title: Ramdomised clinical trial of ivermectin for treatment and prophylaxis of COVID-19 | ||
Medical condition: SARS COVID-19 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005015-40 | Sponsor Protocol Number: IVER-303 | Start Date*: 2021-04-29 | |||||||||||
Sponsor Name:Chemo Research S.L. | |||||||||||||
Full Title: A multicentre, phase III, double-blind, randomised, parallel, placebo-controlled trial to assess efficacy and safety of early administration of Ivermectin during 3 consecutive days to prevent SARS ... | |||||||||||||
Medical condition: Coronavirus disease (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001971-33 | Sponsor Protocol Number: CORIVER | Start Date*: 2020-06-02 |
Sponsor Name:Carmen Hidalgo | ||
Full Title: Pragmatic study "CORIVER": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID-19) | ||
Medical condition: SARS-COV2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002091-12 | Sponsor Protocol Number: HUVE-19-CT-001 | Start Date*: 2020-05-15 |
Sponsor Name:HUVEPHARMA EOOD | ||
Full Title: Multicenter, randomized, double-blind, placebo-controlled study investigating efficacy, safety and tolerability of ivermectin HUVE-19 in patients with proven SARS-CoV-2 infection (COVID-19) and man... | ||
Medical condition: confirmed SARS-CoV-2 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BG (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001474-29 | Sponsor Protocol Number: SAINT | Start Date*: 2020-05-07 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000166-15 | Sponsor Protocol Number: IVM-2021-01 | Start Date*: 2021-03-03 |
Sponsor Name:Meditop Gyógyszeripari Kft | ||
Full Title: A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ivermectin in asymptomatic and mild severity COVID-19 patients | ||
Medical condition: COVID 19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-002283-32 | Sponsor Protocol Number: 2020-34 | Start Date*: 2020-06-12 | |||||||||||
Sponsor Name:OSPEDALE CLASSIFICATO EQUIPARATO SACRO CUORE DON CALABRIA - PRESIDIO OSPEDALIERO ACCREDITATO | |||||||||||||
Full Title: Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19 | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002024-21 | Sponsor Protocol Number: IVER-FNUSA-21 | Start Date*: 2021-06-09 | |||||||||||
Sponsor Name:Fakultní nemocnice u sv. Anny v Brně | |||||||||||||
Full Title: Randomized placebo controlled clinical trial evaluating the safety and efficacy of ivermectin in hospitalized patients with Covid-19 disease | |||||||||||||
Medical condition: Covid-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005423-37 | Sponsor Protocol Number: GHRMRIPH1001 | Start Date*: 2021-02-05 |
Sponsor Name:Raincy Montfermeil intercommunal hospital group | ||
Full Title: Impact évaluation of an ivermectin single dose administration in the early phase of COVID-19 to negative viral load in SARS-CoV-2 determined by RT-PCR_ IVERCoV. | ||
Medical condition: patients with COVID 19 symptoms for less than 72 hours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002340-14 | Sponsor Protocol Number: REMAP-CAP | Start Date*: 2015-09-16 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht | ||||||||||||||||||
Full Title: Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP). (COVID-19) | ||||||||||||||||||
Medical condition: Severe Community Acquired Pneumonia COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) IE (Trial now transitioned) PT (Trial now transitioned) GB (GB - no longer in EU/EEA) HU (Ongoing) BE (Trial now transitioned) DE (Ongoing) HR (Ongoing) ES (Temporarily Halted) FR (Trial now transitioned) FI (Ongoing) IT (Ongoing) CZ (Trial now transitioned) SI (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.